How Much Insulin Resistance in Polycystic Ovary Syndrome? Comparison of HOMA-IR and Insulin Resistance (Belfiore) Index Models
Overview
Authors
Affiliations
Introduction: Polycystic ovary syndrome (PCOS), the commonest endocrinopathy of women in reproductive age, is often accompanied by insulin resistance (IR), hirsutism and/or fertility problems. The aim of the study was to assess the prevalence of IR in women diagnosed with PCOS.
Material And Methods: The study involved 137 women diagnosed with PCOS, according to the Rotterdam consensus criteria (2003). Insulin resistance was assessed according to the HOMA-IR method and insulin resistance (Belfiore) index (IRI) derived from glucose and insulin during the oral glucose tolerance test.
Results: There was a significant ( < 0.0001) but relatively moderate correlation between IRI and HOMA-IR ( = 0.5 and = 0.57 for a linear and non-linear model, respectively). Insulin resistance was more prevalent according to IRI (49.6%) than according to HOMA-IR (22.6% and 15.8% for 3.46 and 3.8 cut-off points, respectively, < 0.01). The majority of patients with high HOMA-IR also had high IRI (e.g. 86%, for HOMA > 3.8), but the majority of patients with raised IRI would not be diagnosed as insulin resistant according to HOMA (61.7% and 73.5%, for HOMA-IR and HOMA-IR, respectively).
Conclusions: The insulin resistance (Belfiore) index indicates more cases of insulin resistance than HOMA-IR in women with PCOS. Therefore, detection of insulin resistance among women with PCOS is highly method-dependent with more severe cases being detected with HOMA-IR than with IRI.
The role of immunity in insulin resistance in patients with polycystic ovary syndrome.
Zhang Q, Yang Z, Ou X, Zhang M, Qin X, Wu G Front Endocrinol (Lausanne). 2025; 15:1464561.
PMID: 39911236 PMC: 11797073. DOI: 10.3389/fendo.2024.1464561.
Tholiya S, Kumari A, Mahey R, Kalaivani M, Sati H, Sharma M J Hum Reprod Sci. 2025; 17(4):240-245.
PMID: 39831090 PMC: 11741119. DOI: 10.4103/jhrs.jhrs_133_24.
MicroRNAs as Biomarkers for Metabolic Disorders in Polycystic Ovary Syndrome (PCOS): A Review.
Dymanowska I, Frankowska K, Krawczyk A, Kociuba J, Gil-Kulik P, Banaszewska B Med Sci Monit. 2024; 30:e946480.
PMID: 39709519 PMC: 11670786. DOI: 10.12659/MSM.946480.
Lupinska A, Aszkielowicz S, Kowalik D, Jeziorny K, Kolasa-Kicinska M, Smalczewska P J Clin Med. 2024; 13(10).
PMID: 38792408 PMC: 11122103. DOI: 10.3390/jcm13102865.
Zhou S, Liu J, Li Z, Yang M, Sha R, Yan R Hypertens Res. 2024; 47(6):1719-1727.
PMID: 38565699 DOI: 10.1038/s41440-024-01648-0.